Autologous coatings for implants

Details Autologous coatings for implants Autologous coatings for implants

2007-05-15

2007-05-15

Wax, Robert A. (Department: 1656)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Implant or insert

C514S012200, C604S508000, C623S013120, C623S017110, C623S022110, C623S022150

Reexamination Certificate

active

11044388

ABSTRACT:
A hydrocephalus shunt having an anti-inflammatory coating applied to at least the outside surface of the ventricular catheter. Such coatings are also applicable to other medical devices or implants.

REFERENCES:
patent: 3886948 (1975-06-01), Hakim
patent: 4332255 (1982-06-01), Hakim et al.
patent: 4387715 (1983-06-01), Hakim et al.
patent: 4551128 (1985-11-01), Hakim et al.
patent: 4595390 (1986-06-01), Hakim et al.
patent: 4615691 (1986-10-01), Hakim et al.
patent: 4772257 (1988-09-01), Hakim et al.
patent: 4816016 (1989-03-01), Schulte et al.
patent: 5176627 (1993-01-01), Watson
patent: 5282864 (1994-02-01), Noiles et al.
patent: 5928182 (1999-07-01), Kraus et al.
patent: 6083919 (2000-07-01), Johnson et al.
patent: 6352557 (2002-03-01), Ferree
patent: 6419944 (2002-07-01), Tobinick
patent: 6503507 (2003-01-01), Allen
patent: 6527759 (2003-03-01), Tachibana et al.
patent: 6592814 (2003-07-01), Wilcox et al.
patent: 6592888 (2003-07-01), Jensen et al.
patent: 6605751 (2003-08-01), Gibbins et al.
patent: 2002/0026244 (2002-02-01), Trieu
patent: 2003/0039651 (2003-02-01), Olmarker
patent: 2003/0049256 (2003-03-01), Tobinick
patent: 2003/0125679 (2003-07-01), Kubota et al.
patent: 2003/0204229 (2003-10-01), Stokes
patent: 2005/0013836 (2005-01-01), Radd
patent: 2005/0048644 (2005-03-01), Hedrick et al.
patent: 2005/0170070 (2005-08-01), Layrolle et al.
patent: 0990924 (2000-04-01), None
patent: WO 02/100387 (2002-12-01), None
Duration of protective activity of cerebrospinal fluid shunt catheters impregnated with antimicrobial agents to prevent bacterial catheter-related infection. Bayston R, Lambert E. J Neurosurg. 1997; 87: 247-251.
Lactoferrin and host defense. Ward PP, Uribe-Luna S, Conneely OM. Biochem Cell Biol. 2002; 80: 95-102. Review.
Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. Kehrl JH, Roberts AB, Wakefield LM, Jakowiew S, Sporn MB, Fauci AS. J Immunol. 1986; 137: 3855-3860.
Role of IL-10 for Induction of Anemia During Inflammation. Tilg, H, Ulmer H, Kaser A, Weiss G. J. Immunol. 2002 15; 169: 2204-2209.
Yokota et al., Adiponectin, A New Member of the Family of Soluble Defense Collagens, Negatively Regulates the Growth of Myelomonocytic Progenitors and the Functions of Macrophages, Blood, 2000, vol. 96, p. 1723-1732.
Ardehali et al., The Inhibitory Activity of Serum to Prevent Bacterial Adhesion is Mainly Due to Apo-transferrin, J. Biomed. Mat. Res., 2003, vol. 66, pp. 21-28.
Alini, Eur. Spine J.,A Biological Approach to Treating Disc Degeneration: Not for Today, but Maybe for Tomorrow,11 (Supp. 2), 2002, pp. S215-220.
Ardehali, J. Biomed.,The Inhibitory Activity of Serum to Prevent Bacterial Adhesion is Mainly Due to Apo-transferrin, Mat. Res., Jul. 1, 2003, 66, 1, pp. 21-28.
Cassatella, J. Exp. Med.Interleukin 10(IL-10)Inhibits the Release of Proinflammatory Cytokines. . . , Dec. 1, 1993, 178(6), pp. 2207-2211.
Cassatella, J. Exp. Med.,Interleukin 10(IL-10Upregulates IL-1 Receptor Antagonist Production. . . , May 1, 1994, 179(5) pp. 1695-1699.
Desai, Anal. Biochem.,Coated Microwell Plate-based Affinity Purification of Antigens, May 15, 2004, 328(2), pp. 162-165.
Diez, Eur. J. Endocrinology,The Role of the Novel Adipocyte-derived Hormone Adiponectin in Human Disease, 2003, 148, pp. 293-300.
Goupille, Spine,Matrix Metalloproteinases: The Clue to Intervertebral Disc Degeneration?, 23(14), 1998, pp. 1612-1626.
Guillen, Arthritis Rheum.,The Effects of Local Administration of Lactoferrin on Inflammation in Murine Autoimmune and Infectious Arthritis, 43, 2000, pp. 2073-2780.
Hayashida, Eur. J. Pharmacology,Lactoferin Enhances Peripheral Opioid-mediated Antinociception via Nitric Oxide in Rats, 484, 2004, pp. 175-181.
Hayashida, J. Vet. Med. Sci.,Oral Administration of Lactoferrin Inhibits Inflammation and Nociception in Rat Adjuvant-Induced Arthritis, 66(2), 2004, pp. 149-154.
Karppinen, Spine,Tumor Necrosis Factor-α Monoclonal Antibody, Infliximab, Used to Manage Severe Sciatia, 28(6), 203, pp. 750-754.
Kurnada, Circulation,Adiponectin Specifically Increased Tissue Inhibitor of Metalloproteinase-1 Through Interleukin-10. . . , May 4, 2004 109(17) pp. 2046-2049.
Matsuda, J. Biol. Chem.,Role of Adiponectin in Preventing Vascular Stenosis, 277(40) pp. 37487-37491.
Motoshima, Biochem. Biophys. Res. Comm.,Adiponectin Suppresses Proliferation and Superoxide Generation and Enhances eNOS Activity. . . , 204, 315, pp. 264-172.
Nakano, J. Biochem (Tokyo),Isolation and Characterization of GBP28, a Novel Gelatin-Binding Protein Purified from Human Plazma, Oct. 1996, 120(4), pp. 803-812.
Ohko, J. Biomed. Mat. Res. (Appl Biomet),Self-Sterilizing and Self-Cleaning of Silicone Catheters Coated with TiO2Photocatalyst Thin Films: A Preclinical Work, 58, 2001, pp. 97-101.
Ouichi, Circulation,Adipocyte-derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression, . . . 103(8), Feb. 27, 2001, p. 1057.
Ouichi, Circulation,Novel Modulator for Endothelial Adhesion Molecules. . . , 1999, 100, pp. 2473-2476.
Brakenhielm, PNAS,Adiponectin-induced Antiangiogenesis and Antitumor Activity Involve Caspase-Mediated Enhothelial Cell Apoptosis, 101(8), pp. 2476-2481.
Shanbhag, J. Biomed. Mar. Res.,Decreased Neutrophil Respiratory Burst on Exposure to Cobalt-Chrome alloy and Polystyrene in vitro, vol. 26, 1992, pp. 185-195.
Shimada, Clin., Chim. Actga.Adiponectin and Atherosclerotic Disease, Jun. 2004, 344(1-2), pp. 1-12.
Singh, Nature,A Component of Innate Immunity Prevents Bacterial Biofilm Development, 417, May 30, 2002, pp. 552-555.
Talukder, J. Vet. Med. Sci.Receptor-Mediated Transport of Lactoferin into the Cerebrospinal Fluid via Plasma in Young Calves,, 65(9), 2003, pp. 957-964.
Taylor, Regul. Toxicol. Pharmacol.Safety Determination for the use of Bovine Milk-derived Lactoferrin as a Component of an Antimicrobial Beef Carcass Spray, Feb. 2004, 39(1), pp. 12-24.
Trampuz, et al.,Clin. Orthop, Molecular and Antibiofilm Approaches to Prosthetic Joint Infection, (414), 2003, pp. 69-88.
Trif, Exp. Biol. Med (Maywood),Liposomes as Possible Carriers for Lactoferrin in the Local Treatment of Inflammataory Diseases, 226(6), 2001, pp. 559-564.
Tobinick, Swiss Med.Weekly,Perispinal TNF-alpha Inhibition for Discogenic Pain, 2003, 133, pp. 170-177.
Wulster-Radcliffe, Biochem, Biophys. Res. Comm.,Adiponectin Differentially Regulates Cytokines in Porcine Macrophages, 316, 2004, pp. 924-929.
Yamamoto, Biochem. Biophys. Res. Comm.,Effect of Interleukin-10 on the Gene Expression of Type I Collagen, Fibronectin, and Decorin in Human Skin Fibroblasts: Differential Regulations by Transforming Growth Factor-β and Monocyte Chemoattractant Protein-1, 316, 2004, pp. 924-929.
Yokota, Blood,Adiponectin, a New Member of the Family of Soluble Defense Collagens, Negatively Regulates the Growth of Myelomonocytic Progenitors and the Functions of Macrophages, Sep. 1, 2000, 96(5), pp. 1723-1732.
Brennen, Rheumatology,Interleukin 10 and Arthritis, 38, 1999, pp. 293-297.
Camody et al., Arthritis & Rheumatism,Viral Interleukin-10 Gene Inhibition of Inflammation. . . , 46(5), May 2002, pp. 1298-1308.
Goodman et al., JBMR,Modulation of Bone Ingrowth and Tissue Differentiation by Local Infusion of Interleukin-10. . . , 65A, 2003, pp. 43-50.
Hart et al., Immunology,Comparison of the suppressive Effects of Interleukin-10 and Interleukin-4 on Synovial Fluid Macrophages and. . . , 84(4), Apr. 1995, pp. 536-542.
Pollice et al., J. Orthop Res.,Interleukin-10 Inhibits Cytokine Synthesis in Monocytes Stimulated by Titanium Particles: . . . , 16(6), Nov. 1998, pp. 697-704.
Trindade et al., Biomaterials,Interleukin-10 Inhibits Polymethylmethacrylate Particle Induced Interleukin-6 and Tumor Necrosis. . . , 22, 2001, pp. 2067-2073.
Hughes et al., Rheumatology,Interleukin 10 and Arthritis, 38, 1999, pp. 293-297.
Maeda, S. et al., Spine,Changes with Age in Proteoglycan Synthesis in Cells Cultured in Vitro from the Inner and Outer Rabbit Annulus Fibrosus, vol. 25(2), 2000, pp. 166-169.
Schierholz J M et al., “Development of A New

Affiliated with

Also associated with

Rating

Autologous coatings for implants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Autologous coatings for implants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Autologous coatings for implants will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3758125